Santaris Pharma raises $12 million in financing - MarketLine Financial Deals

Santaris Pharma raises $12 million in financing

Santaris Pharma raises $12 million in financing - MarketLine Financial Deals
Santaris Pharma raises $12 million in financing
Published Jun 21, 2012
4 pages — Published Jun 21, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Santaris Pharma A/S, a Denmark-based clinical stage biopharmaceutical company, has raised $12 million in a convertible-bond financing.

  
Source:
Document ID
MA114373_120626
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Santaris Pharma raises $12 million in financing" Jun 21, 2012. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Santaris-Pharma-raises-12-million-in-financing-2052-83454>
  
APA:
MarketLine Financial Deals. (2012). Santaris Pharma raises $12 million in financing Jun 21, 2012. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Santaris-Pharma-raises-12-million-in-financing-2052-83454>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.